Development of a virtual spacer to support the decision for the placement of an implantable rectum spacer for prostate cancer radiotherapy: Comparison of dose, toxicity and cost-effectiveness

Published on Aug 16, 2017in Radiotherapy and Oncology4.856
· DOI :10.1016/J.RADONC.2017.07.026
Yvonka van Wijk4
Estimated H-index: 4
Ben G. L. Vanneste14
Estimated H-index: 14
(UM: Maastricht University)
+ 5 AuthorsPhilippe Lambin113
Estimated H-index: 113
(UM: Maastricht University)
Abstract Introduction Previous studies have shown that the implantable rectum spacer (IRS) is not beneficial for all patients. A virtual IRS (V-IRS) was constructed to help identify the patients for whom it is cost-effective to implant an IRS, and its viability as a tool to tailor the decision of an IRS implantation to be beneficial for the specified patient was assessed. Please watch animation: ( ) Materials and methods The V-IRS was tested on 16 patients: 8 with a rectal balloon implant (RBI) and 8 with a hydrogel spacer. A V-IRS was developed using 7 computed tomography (CT) scans of patients with a RBI. To examine the V-IRS, CT scans before and after the implantation of an IRS were used. IMRT plans were made based on CT scans before the IRS, after IRS and with the V-IRS, prescribing 70 Gray (Gy) to the planning target volume. Toxicity was accessed using externally validated normal tissue complication probability (NTCP) models, and the Cost-effectiveness was analyzed using a published Markov model. Results The rectum volume receiving 75 Gy (V75) were improved by both the IRS and the V-IRS with on average 4.2% and 4.3% respectively. The largest NTCP reduction resulting from the IRS and the V-IRS was 4.0% and 3.9% respectively. The RBI was cost-effective for 1 out of 8 patients, and the hydrogel was effective for 2 out of 8 patients, and close to effective for a third patient. The classification accuracy of the model, regarding cost-effectiveness, was 100%. Conclusion The V-IRS approach in combination with a toxicity prediction model and a cost-effectiveness analyses is a promising basis for a decision support tool for the implantation of either a hydrogel spacer or a rectum balloon implant.
📖 Papers frequently viewed together
5 Citations
19 Citations
5 Citations
#1Ben G. L. VannesteH-Index: 14
#2Kees van de Beek (UM: Maastricht University)H-Index: 5
Last. Philippe LambinH-Index: 113
view all 4 authors...
INTRODUCTION: A rectum balloon implant (RBI) is a new device to spare rectal structures during prostate cancer radiotherapy. The theoretical advantages of a RBI are to reduce the high radiation dose to the anterior rectum wall, the possibility of a post-implant correction, and their predetermined shape with consequent predictable position. OBJECTIVE: To describe, step-by-step, our mini-invasive technique for hands-free transperineal implantation of a RBI before start of radiotherapy treatment. M...
8 CitationsSource
#1Daniel A. Hamstra (Texas Oncology)H-Index: 39
#2Neil Mariados (SU: Syracuse University)H-Index: 8
Last. Jeff M. Michalski (WashU: Washington University in St. Louis)H-Index: 73
view all 26 authors...
Purpose SpaceOAR, a Food and Drug Administration–approved hydrogel intended to create a rectal–prostate space, was evaluated in a single-blind phase III trial of image guided intensity modulated radiation therapy. A total of 222 men were randomized 2:1 to the spacer or control group and received 79.2 Gy in 1.8-Gy fractions to the prostate with or without the seminal vesicles. The present study reports the final results with a median follow-up period of 3 years. Methods and Materials Cumulative (...
131 CitationsSource
#1Ben G. L. Vanneste (Maastricht University Medical Centre)H-Index: 14
#2Evert J. Van Limbergen (Maastricht University Medical Centre)H-Index: 11
Last. Philippe Lambin (Maastricht University Medical Centre)H-Index: 113
view all 5 authors...
Radiotherapy (RT) for prostate cancer (PC) has steadily evolved over the last decades, with improving biochemical disease-free survival. Recently population based research also revealed an association between overall survival and doses ≥ 75.6 Gray (Gy) in men with intermediate- and high-risk PC. Examples of improved RT techniques are image-guided RT, intensity-modulated RT, volumetric modulated arc therapy, and stereotactic ablative body RT, which could facilitate further dose escalation. Brachy...
24 CitationsSource
#1Daniel A. Hamstra (Texas Oncology)H-Index: 39
#2N.F. Mariados (SU: Syracuse University)H-Index: 1
Last. J.M. Michalski (WashU: Washington University in St. Louis)H-Index: 14
view all 21 authors...
7 CitationsSource
#1Ben G. L. Vanneste (UM: Maastricht University)H-Index: 14
#2Aswin L. Hoffmann (UM: Maastricht University)H-Index: 17
Last. Philippe Lambin (UM: Maastricht University)H-Index: 113
view all 6 authors...
Abstract Background and purpose Previous studies confirmed that implantable rectum spacers (IRS) decreased acute gastro-intestinal (GI) toxicity in a significant percentage of prostate cancer patients undergoing intensity modulated radiation therapy (IMRT). We developed decision rules based on clinical risk factors (CRFs) to select those patients who are expected to benefit most from IRS implantation. Materials and methods For 26 patients dose distributions with (IMRT+IRS) and without (IMRT−IRS)...
19 CitationsSource
#1Ryan Hutchinson (UTSW: University of Texas Southwestern Medical Center)H-Index: 16
#2Varun Sundaram (UTSW: University of Texas Southwestern Medical Center)H-Index: 4
Last. Yair Lotan (UTSW: University of Texas Southwestern Medical Center)H-Index: 107
view all 4 authors...
Abstract Purpose We conducted a decision analysis to evaluate the cost effectiveness of a newly Food and Drug Administration approved rectal spacer gel (SpaceOAR, Augmenix) for the reduction of rectal toxicity of prostate radiation therapy (RT). Methods A decision tree model (TreeAge Pro) was used to compare the strategy of pretherapy placement of a spacing hydrogel before RT to RT alone. The model compared costs associated with rectal complications because of rectal toxicity over a 10-year peri...
17 CitationsSource
#1Qing Cheng (UM: Maastricht University)H-Index: 2
#2Erik Roelofs (UM: Maastricht University)H-Index: 17
Last. Philippe Lambin (UM: Maastricht University)H-Index: 113
view all 13 authors...
To quantitatively assess the effectiveness of proton therapy for individual patients, we developed a prototype for an online platform for proton decision support (PRODECIS) comparing photon and proton treatments on dose metric, toxicity and cost-effectiveness levels. An evaluation was performed with 23 head and neck cancer datasets.
39 CitationsSource
#1Anusha Kalbasi (UPenn: University of Pennsylvania)H-Index: 16
#2Jiaqi Li (UPenn: University of Pennsylvania)H-Index: 8
Last. Justin E. Bekelman (UPenn: University of Pennsylvania)H-Index: 33
view all 9 authors...
Importance In 5 published randomized clinical trials, dose-escalated external-beam radiation therapy (EBRT) for prostate cancer resulted in improved biochemical and local control. However, scarce evidence addresses whether dose escalation improves overall survival. Objective To examine the association between dose-escalated EBRT and overall survival among men with nonmetastatic prostate cancer. Design, Setting, and Participants We conducted a retrospective, nonrandomized comparative effectivenes...
90 CitationsSource
#1Neil Mariados (SU: Syracuse University)H-Index: 8
#2John SylvesterH-Index: 24
Last. Jeff M. Michalski (WashU: Washington University in St. Louis)H-Index: 20
view all 23 authors...
Purpose Perirectal spacing, whereby biomaterials are placed between the prostate and rectum, shows promise in reducing rectal dose during prostate cancer radiation therapy. A prospective multicenter randomized controlled pivotal trial was performed to assess outcomes following absorbable spacer (SpaceOAR system) implantation. Methods and Materials Overall, 222 patients with clinical stage T1 or T2 prostate cancer underwent computed tomography (CT) and magnetic resonance imaging (MRI) scans for t...
150 CitationsSource
#1Frank Wolf (University of Salzburg)H-Index: 4
#2Christoph Gaisberger (University of Salzburg)H-Index: 5
Last. Felix Sedlmayer (Paracelsus Private Medical University of Salzburg)H-Index: 31
view all 14 authors...
Abstract Background and purpose In external beam radiation (EBRT) of the prostate, the rectum is the dose-limiting organ at risk, and sparing of the anterior rectal wall is a prerequisite for safe delivery of doses beyond 70Gy. Spatial sparing of the rectum can be achieved by introducing a spacer material into the retroprostatic space, thus separating the anterior rectal wall from the PTV. Materials and methods Two spacer technologies, Spacer OAR, a polyethylene glycol gel and ProSpace, a saline...
19 CitationsSource
Cited By10
#1Hamed Hooshangnejad (Johns Hopkins University)
#2Sina Youssefian (Johns Hopkins University)H-Index: 9
Last. Kai Ding (Johns Hopkins University)H-Index: 16
view all 4 authors...
PURPOSE Major advances in delivery systems in recent years have turned radiotherapy (RT) into a more effective way to manage prostate cancer. Still, adjacency of organs at risk (OAR) can severely limit RT benefits. Rectal spacer implant in recto-prostatic space provides sufficient separation between prostate and rectum, and therefore, the opportunity for potential dose escalation to the target and reduction of OAR dose. Pretreatment simulation of spacer placement can potentially provide decision...
#1Yvonka van Wijk (UM: Maastricht University)H-Index: 1
#2Bram Ramaekers (Maastricht University Medical Centre)H-Index: 17
Last. Philippe Lambin (UM: Maastricht University)H-Index: 113
view all 10 authors...
The aim of this study is to build a decision support system (DSS) to select radical prostatectomy (RP) or external beam radiotherapy (EBRT) for low- to intermediate-risk prostate cancer patients. We used an individual state-transition model based on predictive models for estimating tumor control and toxicity probabilities. We performed analyses on a synthetically generated dataset of 1000 patients with realistic clinical parameters, externally validated by comparison to randomized clinical trial...
#1Nicola Rares Franco (Ghent University Hospital)H-Index: 1
#1Nicola Rares Franco (Ghent University Hospital)
Last. Tiziana RancatiH-Index: 27
view all 43 authors...
AIM To identify the effect of single nucleotide polymorphism (SNP) interactions on the risk of toxicity following radiotherapy (RT) for prostate cancer (PCa) and propose a new method for polygenic risk score incorporating SNP-SNP interactions (PRSi). MATERIALS AND METHODS Analysis included the REQUITE PCa cohort that received external beam RT and was followed for 2 years. Late toxicity endpoints were: rectal bleeding, urinary frequency, haematuria, nocturia, decreased urinary stream. Among 43 li...
#1Ramy Abdlaty (McMaster University)H-Index: 4
#2Lilian Doerwald-Munoz (HHS: Hamilton Health Sciences)H-Index: 4
Last. Qiyin Fang (HHS: Hamilton Health Sciences)H-Index: 24
view all 5 authors...
Abstract Skin cancer (SC) is a widely spread disease in the USA, Canada, and Australia. Skin cancer patients are mostly of advanced age and therefore more likely to be treated with radiation therapy as many are comorbid and not surgical candidates. However, radiation therapy has side effects, which may range from skin erythema to skin necrosis. As erythema is the early evidence of exposure to radiation, monitoring erythema is important to prevent more severe reactions. Visual assessment (VA) is ...
#1Owen Paetkau (UVic: University of Victoria)H-Index: 1
#2Isabelle M. Gagne (UVic: University of Victoria)H-Index: 3
Last. Abraham Alexander (UBC: University of British Columbia)H-Index: 5
view all 3 authors...
Prostate cancer external beam radiation therapy can result in toxicity due to organ at risk (OAR) dose, potentially impairing quality of life. A polyethylene glycol-based spacer, SpaceOAR(c) hydrogel (SOH), implanted between prostate gland and rectum may significantly reduce dose received by the rectum and hence risk of rectal toxicity. SOH implant is not equally effective in all patients. Determining patients in which the implant will offer most benefit, in terms of rectal dose reduction, allow...
#1Scott Jones (QUT: Queensland University of Technology)H-Index: 1
#2Catriona Hargrave (QUT: Queensland University of Technology)H-Index: 5
Last. Kerrie Mengersen (QUT: Queensland University of Technology)H-Index: 72
view all 5 authors...
Purpose: Limiting the dose to the rectum can be one of the most challenging aspects of creating a dosimetric external beam radiation therapy (EBRT) plan for prostate cancer treatment. Rectal sparing devices such as hydrogel spacers offer the prospect of increased space between the prostate and rectum, causing reduced rectal dose and potentially reduced injury. This study sought to help identify patients at higher risk of developing rectal injury based on estimated rectal dosimetry compliance pri...
2 CitationsSource
© 2020 The Author(s). Aim:To evaluate the quality of rectal hydrogel spacer (HS) insertions from literature in patients undergoing radical radiotherapy for prostate cancer. The secondary aim is to assess the benefit of HSs in patients with risk factors more likely to have rectal complications, such as non-conventional radiotherapy dose fractionations and high-risk disease.Method and materials:A literature search of peer-reviewed electronic articles was carried out using Boolean connectors and Me...
1 CitationsSource
#1Y. van Wijk (UM: Maastricht University)H-Index: 2
#1Y. Van Wijk (UM: Maastricht University)H-Index: 2
Last. Ben G. L. Vanneste (UM: Maastricht University)H-Index: 14
view all 7 authors...
Background. A multifactorial decision support system (mDSS) is a tool designed to improve the clinical decision-making process, while using clinical inputs for an individual patient to generate case-specific advice. The study provides an overview of the literature to analyze current available mDSS focused on prostate cancer (PCa), in order to better understand the availability of decision support tools as well as where the current literature is lacking. Methods. We performed a MEDLINE literature...
5 CitationsSource
#1Andreas Schörghofer (University of Salzburg)H-Index: 2
#2Martin Drerup (University of Salzburg)H-Index: 4
Last. Frank Wolf (University of Salzburg)H-Index: 4
view all 11 authors...
Background Rectal spacers are used to limit dose to the anterior rectal wall in high dose external beam radiation therapy of the prostate and have been shown to reduce radiation induced toxicity. Here we report the complication rate and toxicity of the implantation procedure in a large cohort of patients who have either received a gel- or balloon-type spacer.
7 CitationsSource
#1Ben G. L. VannesteH-Index: 14
#2Florian Buettner (EMBL-EBI: European Bioinformatics Institute)H-Index: 27
Last. Aswin L. Hoffmann (TUD: Dresden University of Technology)H-Index: 17
view all 5 authors...
Abstract Background and purpose To evaluate spatial differences in dose distributions of the ano-rectal wall (ARW) using dose-surface maps (DSMs) between prostate cancer patients receiving intensity-modulated radiation therapy with and without implantable rectum spacer (IMRT+IRS; IMRT−IRS, respectively), and to correlate this with late gastro-intestinal (GI) toxicities using validated spatial and non-spatial normal-tissue complication probability (NTCP) models. Materials and methods For 26 patie...
5 CitationsSource